Atlantic Therapeutics develops medical devices and accompanying software, apps and technologies for the treatment of incontinence. Their mission is to improve the quality of life for millions of people by restoring and strengthening their pelvic health to help them regain the control and confidence to lead an active life. The product, INNOVO, is an FDA-approved treatment, bearing the CE marking, for women suffering from stress urinary incontinence. It uses unique wearable technology to deliver clinically proven, safe and non-invasive pelvic floor stimulation. This revolutionary tool helps prevent pelvic floor weakness by actively treating the cause, rather than the symptoms. Findings from clinical studies conducted in over 600 test subjects confirm consistent improvements in key results, symptoms and acceptability.